The NIHR has announced the latest outstanding researchers to become NIHR Research Professors. They will play a key role in undertaking professorial-level research that has a positive impact on the ...

US FDA grants priority review status to Johnson & Johnson’s nipocalimab BLA to treat generalized myasthenia gravis: Spring House, Pennsylvania Saturday, January 11, 2025, 12:00 ...

Rochester Institute of Technology hosts AI and Data Science Summit with Vellore Institute of Technology in Chennai: Our ...

Astellas Pharma announces US FDA confirms Class 1 resubmission of the sNDA for Izervay for geographic atrophy: Tokyo Saturday, January 11, 2025, 10:00 Hrs [IST] Astellas Pharma In ...

US FDA accepts for review GSK’s Shingrix new prefilled syringe presentation: London, UK Saturday, January 11, 2025, 09:00 Hrs [IST] GSK plc, a global biopharma company, announce ...

Dr D Ramanathan, managing director of Sitaram Ayurveda Pharmacy, Thrissur and general secretary of the Ayurveda Medicine ...

IDMA plans extensive workshops on revised Schedule M to assist pharma MSMEs: Shardul Nautiyal, Mumbai Saturday, January 11, ...

EU looks at India as best option over China, reflecting potential shifts in trade dynamics: Nandita Vijayasimha, Bengaluru Saturday, January 11, 2025, 08:00 Hrs [IST] The European ...

SMPMA urges govt to drop conditions mandated for extension of revised Schedule M implementation: Gireesh Babu, New Delhi Saturday, January 11, 2025, 08:00 Hrs [IST] The Delhi-base ...

JCR Pharmaceuticals Co., Ltd., a global specialty pharmaceuticals company, and Modalis Therapeutics Corporation, a forerunner in the field of epigenetic medicine, announced that they have validated ...

Acurx Pharmaceuticals, Inc., a late-stage biopharmaceutical company focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, announced that it has ...

Dr Sunita Tandulwadkar takes over as 63rd FOGSI president, unveils bold vision for transforming women’s healthcare in India: ...